The mean percentage of CD24 expression (Percentage of stained cells) in patients with prostate adenocarcinoma (36.69±27.21%) was significantly higher than that of BPH patients (11.61±10.68%) (P<0.001). Here, CD24 is linked to benign prostatic hyperplasia.